1-2 of 2
Esther Drill, DrPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Favorable Outcomes Among Patients with T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Treated with Higher-Intensity Therapy in the Rituximab Era

Edith Tama Robin, MD, Esther Drill, DrPH, Connie Lee Batlevi, MDPhD, Philip Caron, MD PhD, Lorenzo Falchi, MD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Steven M. Horwitz, MD, Andrew M. Intlekofer, MD PhD, Erel Joffe, MD MSc, Anita Kumar, MD, Matthew J Matasar, MD, Ariela Noy, MD, Colette Owens, MD, Maria Lia Palomba, MD, Ildefonso Rodriguez-Rivera, MD, David J. Straus, MD, Santosha Vardhana, MD PhD, Gottfried R. von Keudell, MD PhD, Andrew D Zelenetz, MD PhD, Craig H. Moskowitz, MD, Alison J. Moskowitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–38.
https://doi.org/10.1182/blood-2020-136489
Published: 2020
Journal Articles

IVAC +/- R for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas: Real-World Experience in the Modern Era

Michael J Buege, PharmD, Phuong H Dao, PharmD, Esther Drill, DrPH, Andréa C LeVoir, PharmD, Terry Pak, PharmD, Tim J Peterson, PharmD, David J. Straus, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10.
https://doi.org/10.1182/blood-2020-134607
Published: 2020